Realbotix Corp. XBOTF
—
0.19
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow XBOTF
| Sep '25 | Sep '24 | Sep '23 | |
|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
36.45 | 13.53 | 42.99 |
P/FCF ratio |
43.74 | 0.00 | 0.00 |
P/Operating CF |
(33.24) | (11.53) | (5.05) |
P/B ratio |
20.04 | 1.54 | 1.29 |
Price to Tangible BV |
28.26 | 1.88 | 2.99 |
EV/Sales |
34.39 | 13.59 | 29.96 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(12.78) | (3.05) | (2.49) |
EV/FCF |
41.26 | (4.52) | (3.89) |
Quick Ratio |
2.22 | 0.55 | 4.01 |
Current Ratio |
2.43 | 0.72 | 4.12 |
Net Debt/EBITDA |
0.75 | (0.02) | 2.69 |
Debt/Assets |
14.59% | 12.29% | 0.00% |
Debt/Equity |
0.28 | 0.19 | 0.00 |
Asset Turnover |
0.21 | 0.08 | 0.00 |
Operating CF/Net income |
1.13 | 0.48 | 0.33 |
Capex/Depreciation |
0.00 | 3.31 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (82.19%) | (101.07%) | 0.00% | |
| (49.73%) | (77.55%) | 0.00% | |
ROIC |
0.00% | (28.05%) | (14.94%) |
Return on Tangible Assets |
(132.05%) | 3,402.47% | (348.75%) |
Average Days of Receivables |
24.94 | 16.24 | 121.21 |
Research and Development Expense of Revenue |
37.91% | 39.19% | 0.00% |
Selling, General and Administrative Expense of Revenue |
84.83% | 135.98% | 434.22% |
Intangible Assets out of Total Assets |
0.15 | 0.12 | 0.00 |
Share Based Compensation of Revenue |
20.49% | 31.45% | 55.63% |
Graham Net Nets |
0.03 | (0.18) | 0.24 |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
(6.73%) | (89.13%) | (89.36%) |
Free Cash Flow Yield |
2.29% | (22.22%) | (17.93%) |
Revenue per Share |
0.01 | 0.01 | 0.00 |
Operating CF per Share |
(0.03) | (0.03) | (0.03) |
Capex per Share |
0.00 | 0.01 | 0.01 |
Free Cash Flow per Share |
(0.03) | (0.02) | (0.02) |
Cash per Share |
0.03 | 0.01 | 0.03 |
Shareholders Equity per Share |
0.02 | 0.05 | 0.09 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.02 | 0.05 | 0.09 |
Free Cash Flow |
(5.42) | (2.74) | (2.07) |
Working Capital |
3.41 | (0.75) | 2.79 |
Capital Expenditures |
— | 1.32 | 1.16 |
Net Current Asset Value |
2.38 | (2.25) | 2.74 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | (1.45) | (4.33) |
Net Profit Margin |
(238.22%) | (937.78%) | (3,630.78%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
3.00 | 0.80 | — |
Cash ROIC |
(57.03%) | (41.72%) | (25.98%) |
Accounts Receivable Turnover |
22.60 | 14.08 | 0.00 |
Accounts Payable Turnover |
2.57 | 1.01 | 0.00 |
Inventory Turnover |
3.46 | 0.00 | 0.00 |
Average Days of Payables |
85.00 | 358.76 | 138.34 |
Days of Inventory on Hand |
102.45 | 196.39 | 0.00 |
Average Receivables |
0.09 | 0.06 | — |
Average Payables |
0.51 | 0.72 | — |
Average Inventory |
0.38 | — | — |
Average Assets |
9.65 | 11.03 | — |
Average Common Equity |
5.84 | 8.47 | — |
Columns are period end dates · fundamentals updated 24 Sep 2026